InvestorsHub Logo
Followers 5
Posts 1919
Boards Moderated 1
Alias Born 07/04/2017

Re: mwebb1514 post# 87803

Wednesday, 10/31/2018 1:00:54 PM

Wednesday, October 31, 2018 1:00:54 PM

Post# of 144823
A secondary, yes, I totally agree as its IP alone would be the value driven means of income as licensing deals are struck with those companies in need of CiaB for their own drugs/therapies.

No partner needed. :)


Go Team PharmaCyte!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News